Gaingels Molecule LLC

Amendment

CIK: 0001923844·Other·VERMONT·Filed: Jan 27, 2023

Total Offering

$246,201

Amount Sold

$246,201

Investors

22

First Sale

May 17, 2022

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Limited Liability Company
Year Incorporated: 2022
Non-Accredited Investors: No

Related Persons

Name	Role
David Beatty	Related Person

Company

Gaingels Molecule LLC

3 MAIN STREET

BURLINGTON, VT, 05401

2124047343

SEC Filing

0001923844-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.